Human Liver Models Market - Get to Know More About the Market Segmentation & Geographical Expansion
The global human liver models market is expected to reach USD 2.56 Billion by 2022 from USD 1.35 Billion in 2017, at a CAGR of 13.6% during the forecast period (2017-2022).
(EMAILWIRE.COM, August 23, 2018 ) Browse 7 market data Tables and 2 Figures spread through 37 Pages and in-depth TOC on "Human Liver Models Market"
https://www.marketsandmarkets.com/Market-Reports/human-liver-model-market-171046468.html
Early buyers will receive 10% customization on this report.
The global human liver models market is projected to reach USD 2.56 billion by 2022 from USD 1.35 billion in 2017, at a CAGR of 13.6%.
Growing focus on developing alternatives for animal testing models, significant increase in research funding and venture capital investments for the development of liver models, growing initiatives to increase awareness about liver organoids, increasing research activities on liver organoids, increasing prevalence of non-alcoholic fatty liver disease, and growing need for the early detection of drug toxicity to minimize financial losses due to late-stage drug failure are expected to drive the growth of the human liver models market.
However, issues related to the incorporation of organoids into existing workflows are expected to restrain the growth of this market to a certain extent.
Download the PDF Brochure@
https://www.marketsandmarkets.com/pdfdownload.asp?id=171046468
The human liver models market is segmented on the basis of type and region. By type, the market is segmented into liver organoids, liver-on-a-chip, 2D models, animal models, and 3D bioprinting. The liver-on-a-chip segment is expected to grow at the highest CAGR during the forecast period.
This can be attributed to the simplicity of this model and the ability of on-chip hepatic tissues to maintain metabolic activity and phenotype similar to that of the in vivo environment. Moreover, the majority of key players, research institutes, and government and non-government organizations are raising funds for the development of innovative liver-based models. In addition, key players operating in this market are entering into partnerships and collaborations with pharmaceutical companies to strengthen their market position.
This strategy is enabling market players to evaluate the performance of their livers-on-a-chip offerings in drug development and other pharmaceutical research processes. Such funding initiatives from the government and private investors are expected to provide an impetus to market growth.
Geographically, the human liver models market in North America accounted for the largest share in 2017. This regional segment is also expected to grow at the highest CAGR during the forecast period.
In the US, the human liver models market is driven by the presence of a well-established pharmaceutical and biotechnology industry; growing awareness about the organoids technology through various conferences, workshops, symposia, and trade fairs being organized in the country; favorable government initiatives (in the form of funding and grants); growing incidence of NAFLD, and unavailability of livers for transplantation.
Get the Sample Pages@
https://www.marketsandmarkets.com/requestsample.asp?id=171046468
In Canada, the growth of the human liver models market is driven by the increased spending on research, rising focus on tissue culture-based clinical diagnostics, and the availability of skilled professionals.
The major players in the global human liver model market are Emulate (US), Ascendance Bio (US), HěREL (US), CN Bio (UK), Organovo (US), and Cyfuse Biomedical (Japan).
Target Audience:
# Pharmaceutical and biotechnology companies
# Chemical companies
# Cosmetic product manufacturers, suppliers, and distributors
# Healthcare providers and diagnostic laboratories
# Manufacturers of 3D cell culture products
# Food & beverage manufacturers
# Contract research organizations (CROs)
# Research institutes/universities
# Research and consulting firms
# Venture capitalists
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
https://www.marketsandmarkets.com/Market-Reports/human-liver-model-market-171046468.html
Early buyers will receive 10% customization on this report.
The global human liver models market is projected to reach USD 2.56 billion by 2022 from USD 1.35 billion in 2017, at a CAGR of 13.6%.
Growing focus on developing alternatives for animal testing models, significant increase in research funding and venture capital investments for the development of liver models, growing initiatives to increase awareness about liver organoids, increasing research activities on liver organoids, increasing prevalence of non-alcoholic fatty liver disease, and growing need for the early detection of drug toxicity to minimize financial losses due to late-stage drug failure are expected to drive the growth of the human liver models market.
However, issues related to the incorporation of organoids into existing workflows are expected to restrain the growth of this market to a certain extent.
Download the PDF Brochure@
https://www.marketsandmarkets.com/pdfdownload.asp?id=171046468
The human liver models market is segmented on the basis of type and region. By type, the market is segmented into liver organoids, liver-on-a-chip, 2D models, animal models, and 3D bioprinting. The liver-on-a-chip segment is expected to grow at the highest CAGR during the forecast period.
This can be attributed to the simplicity of this model and the ability of on-chip hepatic tissues to maintain metabolic activity and phenotype similar to that of the in vivo environment. Moreover, the majority of key players, research institutes, and government and non-government organizations are raising funds for the development of innovative liver-based models. In addition, key players operating in this market are entering into partnerships and collaborations with pharmaceutical companies to strengthen their market position.
This strategy is enabling market players to evaluate the performance of their livers-on-a-chip offerings in drug development and other pharmaceutical research processes. Such funding initiatives from the government and private investors are expected to provide an impetus to market growth.
Geographically, the human liver models market in North America accounted for the largest share in 2017. This regional segment is also expected to grow at the highest CAGR during the forecast period.
In the US, the human liver models market is driven by the presence of a well-established pharmaceutical and biotechnology industry; growing awareness about the organoids technology through various conferences, workshops, symposia, and trade fairs being organized in the country; favorable government initiatives (in the form of funding and grants); growing incidence of NAFLD, and unavailability of livers for transplantation.
Get the Sample Pages@
https://www.marketsandmarkets.com/requestsample.asp?id=171046468
In Canada, the growth of the human liver models market is driven by the increased spending on research, rising focus on tissue culture-based clinical diagnostics, and the availability of skilled professionals.
The major players in the global human liver model market are Emulate (US), Ascendance Bio (US), HěREL (US), CN Bio (UK), Organovo (US), and Cyfuse Biomedical (Japan).
Target Audience:
# Pharmaceutical and biotechnology companies
# Chemical companies
# Cosmetic product manufacturers, suppliers, and distributors
# Healthcare providers and diagnostic laboratories
# Manufacturers of 3D cell culture products
# Food & beverage manufacturers
# Contract research organizations (CROs)
# Research institutes/universities
# Research and consulting firms
# Venture capitalists
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
Contact Information:
ReportsnReports
Mr. Shelly Singh
Tel: 1-888-600-6441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsnReports
Mr. Shelly Singh
Tel: 1-888-600-6441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results